Trial Profile
Effects of asunaprevir + daclatasvir combination treatment on liver function, hepatic reserve and the suppression of liver cancer in patients with chronic hepatitis C genotype 1b
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Dec 2015 New trial record